Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
出版年份 2021 全文链接
标题
Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 14, Pages 7518
出版商
MDPI AG
发表日期
2021-07-14
DOI
10.3390/ijms22147518
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma
- (2021) Livnat Jerby-Arnon et al. NATURE MEDICINE
- Germline genetic contribution to the immune landscape of cancer
- (2021) Rosalyn W. Sayaman et al. IMMUNITY
- Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma
- (2021) Rosanna L. Wustrack et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients
- (2021) Angelika M Starzer et al. Journal for ImmunoTherapy of Cancer
- ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas
- (2021) Lucie Darmusey et al. Cancers
- Immune checkpoint inhibitors in treatment of soft-tissue sarcoma: A systematic review and meta-analysis
- (2021) Michael Saerens et al. EUROPEAN JOURNAL OF CANCER
- Molecular determinants of response to PD-L1 blockade across tumor types
- (2021) Romain Banchereau et al. Nature Communications
- A role for SMARCB1 in synovial sarcomagenesis reveals that SS18-SSX induces canonical BAF destruction
- (2021) Jinxiu Li et al. Cancer Discovery
- Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
- (2020) Emily Z. Keung et al. CLINICAL CANCER RESEARCH
- B cells are associated with survival and immunotherapy response in sarcoma
- (2020) Florent Petitprez et al. NATURE
- Epigenetic Therapy for Epithelioid Sarcoma
- (2020) Scott B. Rothbart et al. CELL
- The Immunosuppressive Niche of Soft Tissue Sarcomas is Sustained by Tumor Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures
- (2020) Lingling Chen et al. CLINICAL CANCER RESEARCH
- CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
- (2020) Jordan L Kohlmeyer et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation
- (2020) Valentina Indio et al. Frontiers in Immunology
- Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group
- (2020) Dominga Racanelli et al. Frontiers in Oncology
- Targeted Deep Sequencing Uncovers Cryptic KIT Mutations in KIT/PDGFRA/SDH/RAS-P Wild-Type GIST
- (2020) Annalisa Astolfi et al. Frontiers in Oncology
- The 2020 WHO Classification
- (2020) Michael E. Kallen et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cell Cycle Regulation Meets Tumor Immunosuppression
- (2020) Jinyang Li et al. TRENDS IN IMMUNOLOGY
- Multiomic analysis and immunoprofiling reveal distinct subtypes of human angiosarcoma
- (2020) Jason Yongsheng Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
- (2020) Chuan Hu et al. Journal of Translational Medicine
- Targeting the epigenetic regulation of antitumour immunity
- (2020) Simon J. Hogg et al. NATURE REVIEWS DRUG DISCOVERY
- Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes
- (2020) Yarne Klaver et al. Journal for ImmunoTherapy of Cancer
- High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies
- (2020) Maud Toulmonde et al. EBioMedicine
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
- (2019) Gerardo A. Vitiello et al. JOURNAL OF CLINICAL INVESTIGATION
- Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial
- (2019) Breelyn A Wilky et al. LANCET ONCOLOGY
- CD163+ immune cell infiltrates and presence of CD54+ microvessels are prognostic markers for patients with embryonal rhabdomyosarcoma
- (2019) Jakob Nikolas Kather et al. Scientific Reports
- The current landscape of rhabdomyosarcomas: an update
- (2019) Julia Leiner et al. VIRCHOWS ARCHIV
- Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
- (2019) Kim Bich Nguyen et al. JOURNAL OF CELL BIOLOGY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives
- (2018) Brigitte C. Widemann et al. JOURNAL OF CLINICAL ONCOLOGY
- Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours
- (2018) Armelle Dufresne et al. Nature Reviews Clinical Oncology
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
- (2018) Diana Miao et al. SCIENCE
- Integrated genetic and epigenetic analysis of myxofibrosarcoma
- (2018) Koichi Ogura et al. Nature Communications
- Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
- (2018) David Wang et al. Cell Reports
- Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas
- (2018) Maud Toulmonde et al. JAMA Oncology
- Modulation of EZH2 expression in T cells improves efficacy of anti–CTLA-4 therapy
- (2018) Sangeeta Goswami et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunomodulatory effects of BRAF and MEK inhibitors: Implications for Melanoma therapy
- (2018) Marvin Kuske et al. PHARMACOLOGICAL RESEARCH
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy
- (2018) Alessandra Tuccitto et al. VIRCHOWS ARCHIV
- Loss of PTEN Is Associated with Resistance to Anti-PD-1 Checkpoint Blockade Therapy in Metastatic Uterine Leiomyosarcoma
- (2017) Suzanne George et al. IMMUNITY
- Eight-Color Multiplex Immunohistochemistry for Simultaneous Detection of Multiple Immune Checkpoint Molecules within the Tumor Microenvironment
- (2017) Mark A. J. Gorris et al. JOURNAL OF IMMUNOLOGY
- Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
- (2017) Marcella Tazzari et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Imatinib in Dermatofibrosarcoma: Targeted Therapy or Immunotherapy?
- (2017) Selma Ugurel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
- (2017) Hussein A Tawbi et al. LANCET ONCOLOGY
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
- (2017) Takahiro Tsujikawa et al. Cell Reports
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Transcriptome sequencing identifiesETV6-NTRK3as a gene fusion involved in GIST
- (2016) Monica Brenca et al. JOURNAL OF PATHOLOGY
- Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
- (2016) Alessandro De Vita et al. OncoTargets and Therapy
- Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report
- (2015) Marcella Tazzari et al. BMC CANCER
- New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype
- (2015) J. Lim et al. CLINICAL CANCER RESEARCH
- Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP)
- (2015) S. Stacchiotti et al. CLINICAL CANCER RESEARCH
- Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
- (2014) M Tazzari et al. BRITISH JOURNAL OF CANCER
- Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies
- (2014) Chiara Castelli et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
- (2013) S. Rusakiewicz et al. CANCER RESEARCH
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started